Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children

被引:67
作者
Calonge, Ned [2 ]
Green, Nancy S. [1 ]
Rinaldo, Piero [3 ]
Lloyd-Puryear, Michele [4 ]
Dougherty, Denise [5 ]
Boyle, Coleen [6 ]
Watson, Michael [7 ]
Trotter, Tracy [8 ]
Terry, Sharon F. [9 ]
Howell, R. Rodney [10 ]
机构
[1] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA
[2] Colorado Dept Publ Hlth & Environm, Denver, CO USA
[3] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA
[4] US Hlth Resources & Serv Adm, US Dept HHS, Rockville, MD 20857 USA
[5] Agcy Healthcare Res & Qual, HHS, Rockville, MD USA
[6] Ctr Dis Control & Prevent, HHS, Rockville, MD USA
[7] Amer Coll Med Genet, Bethesda, MD USA
[8] San Ramon Valley Primary Care Med Grp, San Ramon, CA USA
[9] Genet Alliance, Washington, DC USA
[10] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA
关键词
newborn screening; evidence review; nomination; rare condition; advisory committee;
D O I
10.1097/GIM.0b013e3181d2af04
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The Secretary's Advisory Committee on Heritable Disorders in Newborns and Children is charged with evaluating conditions nominated for addition to the uniform screening panel and consequently making recommendations to the secretary of the US Department of Health and Human Services. This report describes the framework by which the committee approaches its task. Key decision nodes include initial review of every nomination to determine whether conditions are amenable for systematic evidence review, review of systematic evidence reviews conducted by the committee's external review group, and deliberation and formal recommendation for addition or exclusion to the uniform panel. Data analyzed include the accuracy and specificity of screening and diagnostic tests for nominated disorders, the extent of predicted health benefits, harms impact on disease course, and cost from early diagnosis and treatment. The committee process is guided by approaches used by similar entities, but more flexible criteria are sometimes needed to accommodate data limitations stemming from the rarity of many of these conditions. Possible outcomes of committee review range from recommendation to add a nominated condition to the uniform panel; provide feedback on specific gaps in evidence that must be addressed before making a decision; or rejection of a nomination (e. g., because of identified harms). The committee's structured evidence-based assessment of nominated conditions supports a consistently rigorous, iterative and transparent approach to its making recommendations regarding broad population-based screening programs for rare conditions in infants and children. Genet Med 2010:12(3):153-159.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 11 条
[1]  
[Anonymous], 1968, PUBLIC HLTH PAP, DOI DOI 10.1001/ARCHINTE.1969.00300130131020
[2]  
[Anonymous], 2000, PEDIATRICS 2, V106, P389
[3]   Comprehensive cost-utility analysis of newborn screening strategies [J].
Carroll, AE ;
Downs, SM .
PEDIATRICS, 2006, 117 (05) :S287-S295
[4]   Committee Report: Advancing the current recommended panel of conditions for newborn screening [J].
Green, Nancy S. ;
Rinaldo, Piero ;
Brower, Amy ;
Boyle, Coleen ;
Dougherty, Denise ;
Lloyd-Puryear, Michele ;
Mann, Marie Y. ;
Howell, Rodney R. .
GENETICS IN MEDICINE, 2007, 9 (11) :792-796
[5]  
MERENSTEIN D, 2006, MENT RETARD DEV D R, V12, P255
[6]  
*NAT RES COUNC COM, 1975, GGEN SCREEN PROGR PR
[7]   Update on the methods of the US preventive services task force: Estimating certainty and magnitude of net benefit [J].
Sawaya, George F. ;
Guirguis-Blake, Anelle ;
LeFevre, Michael ;
Harris, Russell ;
Petitti, Diana .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (12) :871-875
[8]   The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group [J].
Teutsch, Steven M. ;
Bradley, Linda A. ;
Palomaki, Glenn E. ;
Haddow, James E. ;
Piper, Margaret ;
Calonge, Ned ;
Dotson, W. David ;
Douglas, Michael P. ;
Berg, Alfred O. .
GENETICS IN MEDICINE, 2009, 11 (01) :3-14
[9]   National evaluation of US newborn screening system components [J].
Therrell, Bradford L. ;
Hannon, W. Harry .
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2006, 12 (04) :236-245
[10]  
Watson MS, 2006, GENET MED, V8, p1S, DOI 10.1097/01.gim.0000223891.82390.ad